Literature DB >> 9518606

Evidence for physiologically active axonal adenosine receptors in the rat corpus callosum.

T H Swanson1, S E Krahl, Y Z Liu, J A Drazba, S A Rivkees.   

Abstract

Several neurotransmitter receptors have been identified on axons, and emerging evidence suggests that central axonal conduction may be modulated by neurotransmitters. We have recently demonstrated the presence of extra-synaptic adenosine Al receptors along rat hippocampal axons. We now present immunocytochemical evidence for Al receptors on rat corpus callosum axons and show that these receptors actively modulate axon physiology. Using rat brain coronal slices, we stimulated the corpus callosum and recorded the evoked extracellular compound action potential. The lipid-soluble, Al-specific adenosine receptor agonist cyclopentyladenosine, dose-dependently decreased the compound action potential amplitude, an effect reversed by the specific Al antagonist 8-cyclopentyl-1, 3-dipropylxanthine. These data provide the first direct evidence that axonal Al adenosine receptors modulate axon physiology in the adult mammalian brain. Influencing axonal transmission is a potentially powerful mechanism of altering information processing in the nervous system. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9518606     DOI: 10.1016/s0006-8993(97)01323-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Activation of synaptic NMDA receptors by action potential-dependent release of transmitter during hypoxia impairs recovery of synaptic transmission on reoxygenation.

Authors:  A M Sebastião; A de Mendonca; T Moreira; J A Ribeiro
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

2.  Localization and function of dopamine receptors in the subthalamic nucleus of normal and parkinsonian monkeys.

Authors:  Adriana Galvan; Xing Hu; Karen S Rommelfanger; Jean-Francois Pare; Zafar U Khan; Yoland Smith; Thomas Wichmann
Journal:  J Neurophysiol       Date:  2014-04-23       Impact factor: 2.714

3.  The effects of cyclosporin-A on axonal conduction deficits following traumatic brain injury in adult rats.

Authors:  Beverly S Colley; Linda L Phillips; Thomas M Reeves
Journal:  Exp Neurol       Date:  2010-04-01       Impact factor: 5.330

4.  Activation of adenosine₁ receptors induces antidepressant-like, anti-impulsive effects on differential reinforcement of low-rate 72-s behavior in rats.

Authors:  Gerard J Marek
Journal:  J Pharmacol Exp Ther       Date:  2012-02-08       Impact factor: 4.030

5.  PEG-PDLLA micelle treatment improves axonal function of the corpus callosum following traumatic brain injury.

Authors:  Xingjie Ping; Kewen Jiang; Seung-Young Lee; Ji-Xing Cheng; Xiaoming Jin
Journal:  J Neurotrauma       Date:  2014-05-13       Impact factor: 5.269

6.  Preferential neuroprotective effect of tacrolimus (FK506) on unmyelinated axons following traumatic brain injury.

Authors:  Thomas M Reeves; Linda L Phillips; Nancy N Lee; John T Povlishock
Journal:  Brain Res       Date:  2007-04-05       Impact factor: 3.252

Review 7.  Roles of white matter in central nervous system pathophysiologies.

Authors:  Carlos Matute; Bruce R Ransom
Journal:  ASN Neuro       Date:  2012-03-22       Impact factor: 4.146

Review 8.  Axonal activity in vivo: technical considerations and implications for the exploration of neural circuits in freely moving animals.

Authors:  Jeremy M Barry
Journal:  Front Neurosci       Date:  2015-05-06       Impact factor: 4.677

9.  Characterization of NO-producing neurons in the rat corpus callosum.

Authors:  Paolo Barbaresi; Mara Fabri; Emanuela Mensà
Journal:  Brain Behav       Date:  2014-02-12       Impact factor: 2.708

10.  A Novel Approach for Studying the Physiology and Pathophysiology of Myelinated and Non-Myelinated Axons in the CNS White Matter.

Authors:  Lijun Li; Alexander A Velumian; Marina Samoilova; Michael G Fehlings
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.